Techniques and outcomes of bronchoplastic and sleeve resection: an 8-year single-center experience.

BACKGROUND: Bronchial reconstruction is one of the most challenging procedures for thoracic surgeons. This study aimed to report the surgical techniques and clinical outcomes of bronchoplastic and sleeve resection for central lung cancer and summarize our center's experience of this challenging procedure over the past 8 years.
METHODS: Between January 2013 and April 2021, 54 patients underwent a sleeve resection or a lobectomy with bronchoplasty, including 11 patients who received video-assisted thoracoscopic surgery (VATS) bronchial sleeve resection (4 via the uniportal approach and 7 via the biportal approach). Perioperative parameters and surgical short-term patient outcomes were analyzed to evaluate the safety and feasibility of this surgical procedure.
RESULTS: The average operative time and blood loss were 247.8±73.1 (range, 126-455) minutes and 300.4±321.8 (range, 50-1,500) mL, respectively. The mean postoperative length of stay was 10.5±5.8 (range, 4-29) days. Eleven patients underwent additional pulmonary angioplasty or sleeve resection. For patients who underwent biportal VATS sleeve lobectomy, the median operative time was 255 (interquartile range, 179-360) minutes, the median blood loss was 200 (interquartile range, 100-600) mL, and the median postoperative hospital stay was 5 (interquartile range, 5-8) days. For patients who underwent uniportal VATS sleeve lobectomy, the median operative time was 288 (interquartile range, 241.5-343) minutes, the median blood loss was 75 (interquartile range, 50-100) mL, and the median postoperative hospital stay was 5 (interquartile range, 4.5-5.5) days. No anastomosis-related complications or perioperative mortality was observed.
CONCLUSIONS: Both bronchoplastic resection and sleeve resection are safe and feasible procedures. Uniportal thoracoscopic sleeve lobectomy can be performed by skilled surgeons with satisfactory short-term outcomes, although it is surgically complicated. 2021 Translational Lung Cancer Research. All rights reserved.

Introduction

Complete resection, in order to achieve the oncological radicality, is the fundamental purpose of lung cancer treatment. In the past, pneumonectomy was a common choice for centrally located tumors involving the main stem bronchus or main artery, or extending into the origin of the lobar bronchus or artery. However, several publications in recent years revealed that bronchoplastic resection or sleeve lobectomy could be a valid alternative to pneumonectomy. This requires surgeons to complete airway reconstruction while removing the tumor. In fact, these procedures can not only achieve the same oncological outcome, but can also provide lower morbidity and mortality and improve postoperative quality of life by preserving pulmonary function (1-5).

Video-assisted thoracic surgery (VATS) was once considered as a contraindication for bronchoplasty and sleeve lobectomy due to the high risk of complications and the complexity of the operating steps, not to mention uniportal video-assisted thoracic surgery (UVATS). Owing to advancements in imaging systems and innovation of instrument designs, VATS procedures can be performed via the thoracoscopic approach to avoid pneumonectomy in selected patients without compromised lung function. Conventional VATS has been mostly conducted via three or four incisions. Uniportal thoracoscopic sleeve lobectomy was first reported in 2013 by Gonzalez-Rivas et al. (6). Subsequent studies described the more complex uniportal double sleeve resection and bronchoplastic and carinal sleeve procedures (7-11). In the hands of a skilled surgeon, thoracoscopic bronchial sleeve resection is an alternative and effective procedure for resectable central lung tumors, and can even be performed through a single incision. Rapid advances in minimally invasive techniques have also allowed surgeons to skip the multi-portal stage and directly perform biportal or even uniportal surgery in out institution ().

Figure 1

Uniportal video-assisted thoracoscopic right upper sleeve lobectomy in a patient. (A) Preoperative three-dimensional reconstruction of the right pulmonary anatomic structure conducted using Exoview. The bronchi are marked in white; the pulmonary arteries are marked in red; the pulmonary veins are marked in blue; the tumor is marked in yellow. (B) The distal bronchus was transected with scissors to adapt the diameter of the stump of the main bronchus. (C) A tensionless continuous suture was started from the posterior side. (D) The anterior wall of the bronchus was then sutured to complete the reconstruction.

Figure 2

Uniportal video-assisted thoracoscopic left upper sleeve lobectomy in a patient. (A) Preoperative three-dimensional reconstruction of the left pulmonary anatomic structure conducted using Exoview. The bronchi are marked in white; the pulmonary arteries are marked in red; the tumor is marked in yellow. (B) Pulmonary artery suspension devices were used to reduce the complexity of the surgery. (C) A tensionless continuous suture was started from the posterior side. (D) The anterior side of the bronchus was then sutured to complete the reconstruction.

This study reviewed the progress of bronchoplastic and sleeve resection in our institution over the last 8 years, concentrating on surgical outcomes of this challenging technique as well as the safety and feasibility of its application through VATS. We present the following article in accordance with the STROBE reporting checklist (available at https://dx.doi.org/10.21037/tlcr-21-913).

Methods

Patients

We reviewed all cases of bronchoplastic resection or sleeve lobectomy of centrally located tumors invading the main stem bronchus or extending into the origin of the lobar bronchus performed in the Department of Thoracic Surgery of the First Affiliated Hospital of Soochow University (Suzhou, China) between January 2013 and April 2021. Before surgery, bronchoscopy was done to assess the tumor extension and determine the possibility for R0 resection. Enhanced chest computed tomography (CT), enhanced brain magnetic resonance imaging (MRI), whole-body bone scan, and abdominal and bilateral supraclavicular lymph node ultrasonography were routinely performed to exclude metastases. Positron emission tomography (PET)/CT was used as an alternative for patients who could afford it. Since November 2019, our institution has applied preoperative three-dimensional CT bronchography and angiography (3D-CTBA) for the evaluation of pulmonary anatomical structure in patients undergoing lobectomy (). Concrete steps of 3D reconstruction for pulmonary structure have been published previously (12,13).

The indications for bronchoplastic resection or sleeve lobectomy were as follows: (I) centrally located lung tumor invading part of the main bronchus or lobar bronchus; (II) patient pulmonary function adequate to tolerate lobectomy. Systematic lymphadenectomy was conducted in all cases. Patients with distant metastasis were excluded.

This retrospective case series study was approved by the Ethics Committee of The First Affiliated Hospital of Soochow University (ethical approval No. 2021121). Individual consent was waived due to the retrospective nature of this study. Every procedure involving human participants in this study was performed in accordance with the Declaration of Helsinki (as revised in 2013). To protect personal privacy, patient data were handled anonymously.

Surgical procedure

Five thoracic surgeons, each of whom had completed at least 500 cases of pulmonary anatomical resection at our institution, conducted all the surgeries in this study. Most procedures performed during the study period were performed via thoracotomy.

With the accumulation of sufficient VATS and conventional thoracotomy experience in our institution, we have applied biportal thoracoscopic sleeve lobectomy since December 2017, with the first uniportal thoracoscopic sleeve lobectomy being completed in December 2019. However, because of the high technical requirements, most sleeve lobectomy and bronchoplasty procedures are conducted via conventional thoracotomy, even when performed by the most experienced experts in our institution.

The patient was placed in the lateral decubitus position with the healthy side down, and single-lung ventilation general anesthesia was administrated. For conventional thoracotomy, an incision of 10–25 cm in length was made in the 4th or 5th intercostal space, depending on the tumor location and surgical preference of the surgeon. When necessary, a small part of the adjacent intercostal rib was removed to provide optimal exposure. For uniportal surgery, a single incision of 3–4 cm in length was made at the 4th intercostal space along the anterior axillary line, without rib spreading. The incision was routinely covered with a silicon wound protector. With a 10-mm, 30-degree thoracoscope (Karl Storz, Tuttlingen, Germany) positioned at the superior side of the incision, other thoracoscopic instruments were concurrently attached to the single port beneath the thoracoscope. For biportal surgery, another 2-cm assistant incision was made at the 8th intercostal space on the posterior axillary line.

The bronchus was transected with a long handle scalpel and scissors (). To confirm negative resection margins, all specimens were sent for intraoperative frozen sectioning. If the bronchial margin was found to be positive for tumor cells, a 5-mm wide margin would be cut from the positive side of the bronchial circumference each time. To provide more space for manipulation and save time, a systematic lymphadenectomy was routinely performed before the bronchoplasty or anastomosis. Further, the inferior pulmonary ligament was released to free the tension during anastomosis.

For right sleeve lobectomy, the azygos vein arch could be resected depending on surgical needs. For left sleeve lobectomy, pulmonary artery suspension devices could be applied to reduce the surgical complexity and improve the visual field and operating space, especially with the uniportal approach (). Afterward, as shown in and , bronchoplasty or end-to-end bronchial anastomosis was performed with continuous suturing using a single 3-0 prolene suture with a double needle. When performing a pulmonary angioplasty or double-sleeve resection, the surgeon would use a 4-0 prolene suture for vascular anastomosis. Then, a leakage test was performed to confirm no leakage under 30 cmH2O airway pressure. Finally, after the completion of the procedure and depending on the surgical approach, one or two chest tubes were placed.

Perioperative data collection

The demographic features and perioperative results were reviewed for all cases. The clinical data collected included preoperative baseline features [age, sex, smoking history, drinking history, body mass index (BMI), maximum lesion diameter, lesion location, pulmonary function, preoperative complications, and whether neoadjuvant therapy was received], operative characteristics (surgical method, operative time, blood loss and stations, and the number of mediastinal lymph nodes dissected), routine pathological results, and short-term postoperative outcomes (duration and volume of chest drainage, postoperative hospital stay, and postoperative complications and mortality). Postoperative complications were graded according to the Clavien-Dindo classification (14). Minor complications requiring no treatment (i.e., grade I complications) were excluded. The patients’ pathologic stages were assigned with reference to the 8th TNM classification system. Perioperative mortality was defined as any patient death within 30 days after surgery. All the clinical data were collected separately by two investigators from patients’ electronic records using HaiTai 3.0 software (Nanjing, Jiangsu, China). To reduce information bias, any conflicts between the two investigators were adjudicated by a third investigator. The sample size was determined by the number of patients undergoing such surgeries during the study period. All patients were followed up within 1 month after discharge by postoperative outpatient review or telephone.

Statistical analysis

Statistical analyses were performed using IBM SPSS Statistics (version 26.0, IBM Corp., Armonk, NY, USA). Continuous variables were expressed as the mean ± standard deviation (SD) or as the median and range, while categorical data were presented as frequencies and percentages (%).

Results

Between January 2013 and April 2021, 54 patients (50 men and 4 women) with a mean age of 61.2±9.3 (range, 36–80) years underwent a sleeve resection or a lobectomy with bronchoplasty. The clinical baseline characteristics of the patients are described in . Of the 54 patients, 4 had received neoadjuvant chemotherapy. The patients’ tumor stages were classified according to the 8th edition of the American Joint Committee on Cancer TNM classification system and are summarized in . The histological tumor diagnoses are presented in , with squamous cell carcinoma being the most frequent diagnosis (n=43/54).

Table 1

Patient clinical baseline characteristics

Characteristics	Values
Age, years	61.2±9.3 [36–80]
Sex, n (%)
Male	50 (92.6)
Female	4 (7.4)
BMI, kg/m2	23.2±3 (18–30.1)
Smoking history, n (%)	43 (79.6)
Drinking history, n (%)	14 (25.9)
Neoadjuvant therapy, n (%)	4 (7.4)
FEV1, L	2.3±0.6 (1.14–3.75)
%FEV1, %	74.1±14.5 (37.6–102.8)
%MVV, %	71.9±17.5 (35.6–112.5)
Hypertension, n (%)	13 (24.1)
Diabetes mellitus, n (%)	3 (5.5)
Maximal lesion size, cm	3.6±1.7 (1.2–10)
Lesion location, n (%)
Left upper lobe	18 (33.3)
Right upper lobe	31 (57.4)
Left lower lobe	1 (1.9)
Left lower lobe and lingular division	1 (1.9)
Right middle and lower lobe	2 (3.7)
Tracheal carina	1 (1.9)

BMI, body mass index; FEV1, forced expiratory volume in 1 s; %FEV1, percentile forced expiratory volume in 1 second; %MVV, percentile maximal voluntary ventilation.

Table 2

Stage classification

Stage	No. of cases
IB	17
IIA	2
IIB	20
IIIA	12
IIIB	3

Table 3

Histological type of surgically removed specimens

Histological type	No.
Squamous cell carcinoma	43
Adenocarcinoma	4
Atypical carcinoid	1
Mucoepidermoid carcinoma	2
Adenosquamous carcinoma	1
Colorectal carcinoma metastasis	1
Small cell carcinoma	1
Adenoid cystic carcinoma	1
Total	54

All patients were offered an R0 resection. The patients’ surgical outcomes are shown in . The mean operative time and mean blood loss were 247.8±73.1 (range, 126–455) minutes and 300.4±321.8 (range, 50–1,500) mL, respectively. The mean chest tube duration was 8.4±5 (range, 2–26) days, and the mean postoperative length of stay was 10.5±5.8 (range, 4–29) days.

Table 4

Patient surgical outcomes

Outcomes	Values
Operative time, min	247.8±73.1 [126–455]
Blood loss, mL	300.4±321.8 [50–1,500]
Mediastinal lymph nodes dissected
Stations	3.7±1.2 [1–7]
Numbers	13.1±7.9 [2–37]
POD 1 drainage volume, mL	321.4±139.3 [80–750]
Chest tube duration, days	8.4±5 [2–26]
Postoperative length of stay, days	10.5±5.8 [4–29]
Postoperative early complications (grade ≥2), n (%)
Arrhythmia	1 (1.9)
Prolonged air leakage >7 days	18 (33.3)
Bacterial pneumonia	25 (46.3)
Pleural effusion or pneumothorax requiring drainage	1 (1.9)
Severe atelectasis requiring fiberoptic bronchoscopy or tracheotomy	4 (7.4)
Unplanned reoperation	1 (1.9)

POD 1, postoperative day 1.

Due to the local extent of tumor invasion, some patients underwent additional surgical procedures, which are detailed in . Eleven patients underwent an additional pulmonary angioplasty or sleeve resection. In one case, superior vena cava replacement was conducted due to palpation of the tumor thrombus in the superior vena cava during the operation. In another case, part of the pericardium and the left atrium was removed due to tumor invasion. Systematic lymph node dissection was conducted after lesion resection, and malignancy was confirmed by frozen section examination. The average numbers of mediastinal lymph node stations and lymph nodes dissected were 3.7±1.2 (range, 1–7) and 13.1±7.9 (range, 2–37), respectively.

Table 5

Distribution per type of bronchoplasty and sleeve resection

Surgical method	No.
Lobectomy with bronchoplasty	5
Sleeve lobectomy	32
Double-sleeve lobectomy	5
Half-carinal sleeve resection	3
Carinal sleeve resection	1
Bronchoplasty with pulmonary angioplasty or vascular sleeve resection	2
Sleeve lobectomy with pulmonary angioplasty	4
Sleeve lobectomy with replacement of superior vena cava	1
Sleeve lobectomy with pericardial and atrial resection	1
Total	54

Bacterial pneumonia was the most common postoperative complication (n=25/54), followed by prolonged (>7 days) air leakage (n=18/54). All affected patients were managed conservatively through adjusting antibiotic use and replacing the negative pressure drainage bottle. Severe atelectasis occurred in 4 patients (7.4%), 3 of whom underwent fiberoptic bronchoscopy for efficient aspiration of the secretions, and 1 had a tracheotomy. One patient (1.9%) experienced postoperative bleeding following a right upper sleeve lobectomy, from the mediastinal pleura in front of the superior vena cava. Consequently, the patient underwent unplanned reoperation on day 16 after the first operation. One patient (1.9%) developed paroxysmal atrial fibrillation postoperatively, and sinus rhythm was restored after amiodarone administration. Another patient (1.9%) received closed thoracic drainage on days 7 and 8 after surgery, due to pleural effusion and pneumothorax. There were no cases of readmission or 30-day mortality.

Eleven VATS sleeve lobectomies (4 via the uniportal approach and 7 via the biportal approach) were completed uneventfully without conversion to conventional thoracotomy. The detailed clinical data of these cases are listed in . No perioperative mortality was reported. The first case was performed using a conventional two-port approach in December 2017. The median operative time was 255 (interquartile range, 179–360) minutes, and the median blood loss was 200 (interquartile range, 100–600) mL. The median number of mediastinal lymph nodes dissected was 8 (interquartile range, 3–12), and the median postoperative hospital stay was 5 (interquartile range, 5–8) days. One patient developed pulmonary infections after surgery but recovered uneventfully after their antibiotic use was adjusted. Another patient suffered prolonged air leakage and was treated with conservative therapy for 20 days. Pathological findings of the 7 cases in which the biportal approach was used included 4 cases of squamous cell carcinoma, 1 case of adenocarcinoma, 1 case of mucoepidermoid carcinoma, and 1 case of atypical carcinoid. TNM staging of non-small cell lung cancer revealed 3 cases with stage IB, 3 patients with stage IIB, and 1 patient with stage IIIA. After December 2019, another 4 uniportal surgeries mentioned above were conducted successively. One of the patients received 2 cycles of neoadjuvant chemotherapy (docetaxel + carboplatin). The median operative time was 288 (interquartile range, 241.5–343) minutes, and the median blood loss was 75 (interquartile range, 50–100) mL. The median number of mediastinal lymph nodes dissected was 13 (interquartile range, 6.5–18), and the median postoperative hospital stay was 5 (interquartile range, 4.5–5.5) days. One patient suffered pulmonary infection after surgery but recovered uneventfully after antibiotic escalation. All the cases were diagnosed as squamous cell carcinoma. TNM staging of non-small cell lung cancer revealed 1 case of IB and 3 cases of IIB.

Table 6

Perioperative parameters of patients who underwent biportal video-assisted thoracoscopic sleeve lobectomy

Parameters	Values
Median age, years, [IQR]	57 [52–62]
Sex, n (%)
Male	5 (71.4)
Female	2 (28.6)
Neoadjuvant therapy, n (%)	0
Median maximal lesion size, cm, [IQR]	3 [1.5–4]
Lesion location, n (%)
Left upper lobe	3 (42.9)
Right upper lobe	4 (57.1)
Histological type, n (%)
Squamous cell carcinoma	4 (57.1)
Adenocarcinoma	1 (14.3)
Atypical carcinoid	1 (14.3)
Mucoepidermoid carcinoma	1 (14.3)
Median operative time, min, [IQR]	255 [179–360]
Median blood loss, mL, [IQR]	200 [100–600]
Median mediastinal lymph nodes dissected, n [IQR]
Stations	3 [3–4]
Numbers	8 [3–12]
TNM stage, n (%)
IB	3(42.9)
IIB	3 (42.9)
IIIA	1 (14.3)
Median POD 1 drainage volume, ml, [IQR]	370 [250–400]
Median chest tube duration, days, [IQR]	4 [3–6]
Median postoperative length of stay, days, [IQR]	5 [5–8]
Postoperative early complications (grade ≥2), n (%)
Prolonged air leakage >7 days	1 (14.3)
Bacterial pneumonia	1 (14.3)

POD 1, postoperative day 1; IQR, interquartile range.

Table 7

Perioperative parameters of patients who underwent uniportal video-assisted thoracoscopic sleeve lobectomy

Parameters	Values
Median age, years, [IQR]	63.5 [56.5–70.5]
Sex, n (%)
Male	4 (100.0)
Female	0
Neoadjuvant therapy, n (%)	1 (25.0)
Median maximal lesion size, cm, [IQR]	2.5 [2.1–3.75]
Lesion location, n (%)
Left upper lobe	1 (25.0)
Right upper lobe	3 (75.0)
Histological type, n (%)
Squamous cell carcinoma	4 (100.0)
Median operating time, min, [IQR]	288 [241.5–343]
Median blood loss, mL, [IQR]	75 [50–100]
Median mediastinal lymph nodes dissected, n [IQR]
Stations	4 [3–5]
Numbers	13 [6.5–18]
TNM stage, n (%)
IB	1 (25.0)
IIB	3 (75.0)
Median POD 1 drainage volume, mL, [IQR]	100 [90–160]
Median chest tube duration, days, [IQR]	4 [3–4.5]
Median postoperative length of stay, days, [IQR]	5 [4.5–5.5]
Postoperative early complications (grade ≥2), n (%)
Bacterial pneumonia	1 (25.0)

POD 1, postoperative day 1; IQR, interquartile range.

Discussion

The first bronchial sleeve resection was performed by Thomas for a patient with a right main bronchus tumor in 1956 (15). Since then, multiple publications have shown that sleeve lobectomy reduces lung function loss and improves surgical mortality and survival rates compared with pneumonectomy (1-5,16). Additionally, sparing lung parenchyma can undoubtedly improve the quality of life of patients after surgery due to them having a greater pulmonary reserve, which has been advocated as one of the most reliable indicators influencing the decision to perform a sleeve lobectomy. Therefore, an increasing number of thoracic surgeons prefer sleeve resection as an alternative to pneumonectomy for patients with central lung cancer. Despite the unquestionable benefits of bronchial reconstruction in preventing pneumonectomy, most of these procedures are still performed by thoracotomy in our institution due to their complexity.

At one time, VATS was considered to be a technically restricted area for sleeve lobectomy and bronchoplasty. Major concerns have surrounded the completeness of oncologic resection and the safety of anastomosis. Due to technical difficulties in anatomical reconstruction and airway management, the use of a thoracoscopic approach for these procedures represents a challenge, even for experienced thoracic surgeons. Nevertheless, minimally invasive technologies have developed rapidly over the past 20 years, and the advent of UVATS has accelerated this evolution. In 2002, the development of new instruments and experience accumulated from conventional thoracoscopic lobectomies made this method possible by Santambrogio et al. (17). After sufficient experience gained with biportal and uniportal VATS, authors first performed the VATS sleeve bronchoplasty for a patient with mucoepidermoid carcinoma of the left lower lobar bronchus in 2017. Interestingly, conventional VATS has been mostly performed with three or four incisions. Owing to rapid development of surgical instruments and techniques, multi-portal VATS may not be a necessary learning stage for bronchoplastic or sleeve resection.

Although UVATS provides direct vision and is a similar surgical approach to thoracotomy, it entails a restricted visual field and causes interference between surgical instruments. End-to-end anastomosis of the bronchus is an extremely challenging procedure using a UVATS approach. To our knowledge, in China, only a few experienced surgical teams in high-volume centers have successfully adopted UVATS for bronchial sleeve resection (9,11,18,19) since it was first reported by Gonzalez-Rivas et al. in 2013 (6). Zhao et al. (11) highlighted that UVATS shows a trend toward a reduction of patients’ postoperative pain and shorter postoperative hospital stay, also helping to alleviate the corresponding financial burden. Another advantage of UVATS is its superior cosmetic results, which is, to some extent, important for young patients. In December 2017, our unit conducted the first biportal VATS left upper sleeve lobectomy, and since December 2019, 4 successive UVATS sleeve lobectomies have been performed uneventfully without conversion to thoracotomy. All the uniportal surgeries were completed by the same surgeon (J. Zhao). Vascular and carinal reconstructions are known to be more difficult than bronchial reconstruction, although Gonzalez-Rivas successfully completed these procedures using a single port approach (20,21). Given the complexity of the procedure and our lack of surgical experience, we have yet to apply the uniportal technique in complex sleeve resection such as double-sleeve lobectomy, half-carinal, and carinal sleeve resection.

In order to conduct VATS sleeve lobectomy successfully, we summarize our experience from three aspects. First, the proper patient selection and an adequate preoperative evaluation. Patients with large central tumors should undergo careful assessment, including the relationship between the tumor, hilar vessels, and lymph nodes. Enhanced CT scans and bronchoscopy are also necessary, and three-dimensional reconstruction, which can provide a more stereo and concrete observation of the pulmonary anatomical structures, is recommended if possible. Second, our research revealed that it is more difficult to carry out the reconstruction procedures after neoadjuvant therapy not only due to the narrowing of the space between vessels and the bronchus, but also for the increase in vascular fragility and toughness of the mediastinal lymph nodes. These considerations are in agreement with the experience of Liang et al. (22). Moreover, sufficient exposure of the operating space is also crucial, and the field of vision offered by a single incision is limited. This disadvantage becomes even more apparent during left upper sleeve lobectomy due to the obstruction of the aortic arch. Therefore, based on Huang’s report (19), we used a set of pulmonary artery suspension devices to expose the bronchus and greatly reduce the interference from the pulmonary artery, thus preventing injury to the anastomotic stoma. In addition, preferential dissection of mediastinal lymph nodes can provide an excellent field of view when conducting anastomosis. Third, considering that sleeve resection is a particularly complex procedure, there is no convincing evidence favoring interrupted or continuous sutures for bronchial anastomosis at present. Based on our limited experience, we recommend complete continuous suture to enable a tension-free anastomosis, which seems to be safe and with no anastomosis-related complications, such as bronchopleural fistula or anastomotic stricture. A double needle with 3-0 prolene sutures should be used to avoid intertwining. Further, according to Zhou’s study (23), knots placed in the bronchial lumen may cause irritable cough, retention of secretions, or even anastomotic stricture. A continuous seam ensures better visibility and more manipulation space for the surgeon. Meanwhile, releasing the inferior pulmonary ligament and freeing the bronchus for as long as possible can ensure a tension-free anastomosis. In addition to allowing for easier manipulation, these techniques could also greatly reduce the operative time.

The major concern with sleeve lobectomy and bronchoplasty relates to anastomosis-related complications, such as bronchopleural fistula or anastomotic stricture. Tapias et al. (24) reported an incidence rate to 0–8.1% of bronchopleural fistula in patients undergoing sleeve resection. A meta-analysis published in 2012 observed that postoperative morbidity and mortality hinge on the healing of the anastomosis (25). However, no such complications were observed in our cohort. In our institution, intra- and postoperative bronchoscopy was not carried out as a routine surveillance procedure without strong clinical indication such as unsatisfactory intraoperative anastomosis procedure, severe atelectasis or high suspicion of complications associated with anastomosis. Pulmonary infection and air leakage were two of the most common complications in our series. All the patients with these complications were treated conservatively by upgrading antibiotics or applying a negative pressure drainage system. However, the incidence of pneumonia is very high (near 50%). A possible cause is different evaluation criteria. We adjust treatment plan mainly according to blood routine test or imaging results such as bedside chest radiography instead of strict bacteriological examination. Interestingly, there was an incidence of 2/11 cases (near 20%) of bacterial pneumonia during the postoperative period among patients treated through VATS, which is lower than the one treated through thoracotomy. However, we did not perform statistical comparison between groups due to the sample size.

This retrospective study has some limitations. First, because all the patients were treated at a single center, the sample size was small. Second, the investigators had to rely on old patient e-files, which are not always complete and precise, and may have led to errors. Third, no long-term follow-up data, such as 5-year disease-free survival or overall survival, were analyzed in our study, as we could not obtain accurate information regarding loco-regional recurrence or long-term survival. In future, a high-volume prospective randomized controlled trial needs to be conducted to confirm the advantages of UVATS on perioperative and long-term outcomes.

Conclusions

In conclusion, both bronchoplastic resection and sleeve resection are safe and feasible procedures. Although this is a small retrospective case series, our experience shows that uniportal thoracoscopic sleeve lobectomy can be performed by skilled surgeons with satisfactory short-term outcomes, although it is surgically complicated.

The article’s supplementary files as